STAR PHARMA AS
4820 FROLAND
Return on Equity
35,9Â %
Current Ratio
1,36
Debt-to-Equity Ratio
0
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 232Â 000 | |
| Net Income | 14Â 000 | |
| Total Assets | 146Â 000 | |
| Total Equity | 39Â 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 232Â 000 | |
| Expenditure | 213Â 000 | |
| Operating Profit | 19Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 2Â 000 | |
| Financial Balance | −2 000 | |
| Earnings Before Tax | 17Â 000 | |
| Tax | 2Â 000 | |
| Net Income | 14Â 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 0 | |
| Total Current Assets | 146Â 000 | |
| Total Assets | 146Â 000 | |
| Total Retained Equity | 14Â 000 | |
| Total Equity | 39Â 000 | |
| Total Long-Term Debt | 0 | |
| Total Current Debt | 107Â 000 | |
| Total Equity and Debt | 146Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 232Â 000 | |
| Other Income | 0 | |
| Revenue | 232Â 000 | |
| Cost of Goods Sold | 49Â 000 | |
| Salary Costs | 0 | |
| Depreciation | 0 | |
| Impairment | 0 | |
| Expenditure | 213Â 000 | |
| Operating Profit | 19Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 2Â 000 | |
| Financial Balance | −2 000 | |
| Dividends | 0 | |
| Net Income | 14Â 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 0 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 0 | |
| Total Tangible Assets | 0 | |
| Total Fiancial Fixed Assets | 0 | |
| Total Fixed Assets | 0 | |
| Stock | 113Â 000 | |
| Total Investments | 0 | |
| Cash, Bank | 30Â 000 | |
| Total Current Assets | 146Â 000 | |
| Total Assets | 146Â 000 | |
| Total Equity | 39Â 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 0 | |
| Creditors | 30Â 000 | |
| Unpaid Taxes | 7Â 000 | |
| Dividends | 0 | |
| Other Current Debt | 68Â 000 | |
| Total Current Debt | 107Â 000 | |
| Total Equity and Debt | 146Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 35,9Â % | |
| Debt-to-Equity Ratio | 0 | |
| Operating Profit Margin | 8,19Â % | |
| Current Ratio | 1,36 | |
| Quick Ratio | −24,33 | |
| Equity Ratio | 0,27 | |
| Gross Profit Margin | 78,88Â % |
Rotate your device to see the full table